NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas

Nishanth S Sadagopan1,2, Mateo Gomez1,2, Shashwat Tripathi1,2

  • 1Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Journal of Neuro-Oncology
|September 9, 2025
PubMed
Abstract

Insights

NOTCH3 signaling drives aggressive meningioma by promoting fatty acid oxidation, depleting lipids, and conferring resistance to ferroptosis. This metabolic reprogramming highlights potential therapeutic vulnerabilities in NOTCH3-positive tumors.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Molecular Biology

Background:

  • NOTCH3 signaling is implicated in various cancers, including meningiomas.
  • Prior research links NOTCH3 expression to higher-grade meningiomas and treatment resistance.
  • The metabolic phenotype associated with NOTCH3 activation in meningioma remains largely unexplored.

Purpose of the Study:

  • To investigate the metabolic consequences of NOTCH3 activation in meningioma.
  • To explore the role of NOTCH3 in lipid metabolism and ferroptosis evasion.
  • To identify potential therapeutic targets based on NOTCH3-mediated metabolic alterations.

Main Methods:

  • Single-cell RNA sequencing of NOTCH3-positive meningioma cell lines.
  • Overexpression of NOTCH3 intracellular domain (ICD) in the CH157-MN cell model.
  • Untargeted metabolomic, lipidomic, bulk RNA sequencing, and functional metabolic assays.

Main Results:

  • NOTCH3 activation promotes fatty acid oxidation (FAO), depleting lipid pools and increasing resistance to ferroptosis.
  • NOTCH3 expression correlates with CD36, a fatty acid transporter, and enhanced mitochondrial respiration.
  • Overexpression of NOTCH3 ICD leads to upregulation of FAO genes and resistance to ferroptosis, reversible with CPT1 inhibition.

Conclusions:

  • NOTCH3 signaling is linked to lipid metabolic reprogramming and ferroptosis evasion in aggressive meningioma.
  • This metabolic shift contributes to the malignant behavior of NOTCH3-positive meningiomas.
  • The findings offer novel insights into the biochemical vulnerabilities of meningioma, suggesting potential therapeutic strategies targeting NOTCH3-driven metabolism.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.2K